LeMaitre Vascular, Inc. (LMAT) compared with its closest peers (PLSE, ATRC, UFPT, INSP, KMTS): P/E 28.6 vs industry 32.9. Peer set by Business model: Medical Devices / Life Science Tools; 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Pulse Biosciences, Inc. (PLSE) | $3.42B | -12.7 |
| AtriCure, Inc. (ATRC) | $2.42B | 229.1 |
| UFP Technologies, Inc. (UFPT) | $2.36B | 34.5 |
| Inspire Medical Systems, Inc. (INSP) | $1.77B | 18.8 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | $1.59B | -8.5 |
| Tandem Diabetes Care, Inc. (TNDM) | $1.55B | -7.2 |
| Alphatec Holdings, Inc. (ATEC) | $1.43B | -21.9 |
| Artivion, Inc. (AORT) | $1.36B | 217.3 |
| Integra LifeSciences Holdings Corporation (IART) | $1.29B | -1.8 |
| PROCEPT BioRobotics Corporation (PRCT) | $1.18B | -18.3 |
| Stock P/E | 28.6 |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Medical Equipment) | 32.9 |
| vs Sector | 32.6% |
| vs Industry | -12.9% |
LMAT overview · LMAT earnings · LMAT financials · LMAT KPIs · LMAT investor relations · LMAT ownership · LMAT filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.